SCHEMBL31494035

SCHEMBL31494035

Cc1ccc(S(=O)(=O)OCCOCC2CN(C(=O)OC(C)(C)C)CCO2)cc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHA2 P29317 4/20 0.42
PDK1 Q15118 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MMP13 P45452 1/20 0.40
GPR119 Q8TDV5 7/20 0.39
ERBB2 P04626 1/20 0.39
EPHB4 P54760 1/20 0.39
P2RX3 P56373 3/20 0.37
P2RX2 Q9UBL9 3/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
P2RX7 Q99572 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL617821 0.91 PDK1 (0.45) EPHA2PDK1KMT2AMEN1MMP13
SCHEMBL617822 0.91 PDK1 (0.45) EPHA2PDK1KMT2AMEN1MMP13
SCHEMBL618014 0.91 PDK1 (0.45) EPHA2PDK1KMT2AMEN1MMP13
SCHEMBL12527484 0.89 KMT2A (0.43) EPHA2PDK1KMT2AMEN1MMP13
SCHEMBL7291444 0.82 STS (0.49) EPHA2KMT2AMEN1GPR119ERBB2
SCHEMBL14835647 0.81 EPHA2 (0.45) EPHA2MMP13GPR119ERBB2EPHB4
SCHEMBL14835600 0.81 EPHA2 (0.45) EPHA2MMP13GPR119ERBB2EPHB4
SCHEMBL14835601 0.81 EPHA2 (0.45) EPHA2MMP13GPR119ERBB2EPHB4
SCHEMBL9214380 0.80 ALDH1A1 (0.49) EPHA2MMP13GPR119ERBB2EPHB4
SCHEMBL9216185 0.80 ALDH1A1 (0.49) EPHA2MMP13GPR119ERBB2EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085815-A1 PROTAC COMPOUNDS BINDING KEAP1 UBIQUITIN LIGASE FOR TARGETED PROTEIN DEGRADATION SEED THERAPEUTICS US, INC. (US) 2025-04-24 WO disclosed
WO-2025083472-A2 PROTAC COMPOUNDS BINDING KEAP1 UBIQUITIN LIGASE FOR TARGETED PROTEIN DEGRADATION SEED THERAPEUTICS US, INC. (US) 2025-04-24 WO disclosed